Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and betadex

angiotensin ii, des-phe(8)- has been researched along with betadex in 2 studies

Compound Research Comparison

Studies
(angiotensin ii, des-phe(8)-)
Trials
(angiotensin ii, des-phe(8)-)
Recent Studies (post-2010)
(angiotensin ii, des-phe(8)-)
Studies
(betadex)
Trials
(betadex)
Recent Studies (post-2010) (betadex)
1,533219958,785974,452

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Lima, GF; de Sousa, FB; Denadai, AL; Duarte, HA; Heine, T; Lula, I; Pilo-Veloso, D; Resende, JM; Santos, RA; Sinisterra, RD1
Becker, L; Bertagnolli, M; Casali, KR; Dartora, DR; De Sousa, FB; Dias, LD; Irigoyen, MC; Milan, RD; Pinto, G; Rigatto, K; Santos, RA; Santos, SH; Schaan, BD1

Other Studies

2 other study(ies) available for angiotensin ii, des-phe(8)- and betadex

ArticleYear
Study of angiotensin-(1-7) vasoactive peptide and its beta-cyclodextrin inclusion complexes: complete sequence-specific NMR assignments and structural studies.
    Peptides, 2007, Volume: 28, Issue:11

    Topics: Angiotensin I; beta-Cyclodextrins; Circular Dichroism; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Peptide Fragments; Protein Structure, Secondary; Protein Structure, Tertiary

2007
An orally active angiotensin-(1-7) inclusion compound and exercise training produce similar cardiovascular effects in spontaneously hypertensive rats.
    Peptides, 2014, Volume: 51

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Angiotensin I; Animals; Antihypertensive Agents; beta-Cyclodextrins; Blood Pressure; Combined Modality Therapy; Drug Evaluation, Preclinical; Excipients; Exercise Therapy; Heart Rate; Hypertension; Male; Myocardium; Peptide Fragments; Physical Conditioning, Animal; Rats; Rats, Inbred SHR; Ventricular Pressure

2014